- Home
- PRQR vs CFFI Comparison
PRQR vs CFFI Comparison
Compare PRQR & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- CFFI
- Stock Information
- Founded
- PRQR 2012
- CFFI 1927
- Country
- PRQR Netherlands
- CFFI United States
- Employees
- PRQR N/A
- CFFI N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- CFFI Major Banks
- Sector
- PRQR Health Care
- CFFI Finance
- Exchange
- PRQR Nasdaq
- CFFI Nasdaq
- Market Cap
- PRQR 309.5M
- CFFI 248.5M
- IPO Year
- PRQR 2014
- CFFI 1998
- Fundamental
- Price
- PRQR $2.67
- CFFI $72.05
- Analyst Decision
- PRQR Strong Buy
- CFFI
- Analyst Count
- PRQR 5
- CFFI 0
- Target Price
- PRQR $7.60
- CFFI N/A
- AVG Volume (30 Days)
- PRQR 603.0K
- CFFI 11.3K
- Earning Date
- PRQR 11-07-2024
- CFFI 01-22-2025
- Dividend Yield
- PRQR N/A
- CFFI 2.44%
- EPS Growth
- PRQR N/A
- CFFI N/A
- EPS
- PRQR N/A
- CFFI 5.66
- Revenue
- PRQR $20,506,357.00
- CFFI $114,783,000.00
- Revenue This Year
- PRQR $235.11
- CFFI N/A
- Revenue Next Year
- PRQR N/A
- CFFI N/A
- P/E Ratio
- PRQR N/A
- CFFI $12.56
- Revenue Growth
- PRQR 306.68
- CFFI N/A
- 52 Week Low
- PRQR $1.61
- CFFI $33.51
- 52 Week High
- PRQR $4.62
- CFFI $80.87
- Technical
- Relative Strength Index (RSI)
- PRQR 38.02
- CFFI 45.96
- Support Level
- PRQR $2.48
- CFFI $71.05
- Resistance Level
- PRQR $2.71
- CFFI $73.44
- Average True Range (ATR)
- PRQR 0.29
- CFFI 2.26
- MACD
- PRQR -0.08
- CFFI -1.20
- Stochastic Oscillator
- PRQR 28.09
- CFFI 10.18
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
About CFFI C&F Financial Corporation
C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum revenue from the Community Banking segment.